{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:53:30Z","timestamp":1782845610662,"version":"3.54.5"},"reference-count":72,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\u00a0Approximately 75% of people with pancreatic cancer experience pain, and &gt;50% of them have cachexia (weakness and wasting of the body). However, there is considerable uncertainty regarding the management of these distressing symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\u00a0Our primary objectives are to compare the relative benefits and harms of different interventions for pain in people with unresectable pancreatic cancer and for prevention and treatment of cachexia due to pancreatic cancer, through systematic reviews and network meta-analysis. Our secondary objectives are to develop an evidence-based clinical care pathway to manage pain and prevent and treat cachexia in people with pancreatic cancer through surveys and focus groups involving patients, carers, and health care professionals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\u00a0We will perform 2 systematic reviews of the literature related to pain and cachexia in people with pancreatic cancer using searches from Cochrane Library, MEDLINE, Embase, Science Citation Index, and trial registries. Two researchers will independently screen for eligibility and identify randomized controlled trials (no language or publication status restriction), comparing interventions for pain or cachexia based on full-texts for articles shortlisted during screening. We will assess risk of bias in the trials using the Cochrane risk of bias tool (version 2.0) and obtain data related to baseline prognostic characteristics, potential effect modifiers and outcome data related to overall survival, health-related quality of life, treatment-related complications, and resource utilisation. We aim to conduct network meta-analysis on outcomes with multiple treatment comparisons where possible, otherwise, meta-analysis with direct comparisons, or narrative synthesis. We will perform various subgroup and sensitivity analyses. Using information obtained from both systematic reviews, we will conduct 2 surveys: one directed to patients or carers to assess acceptability of interventions, and the other to health care professionals to assess feasibility of delivery in the National Health Service. Four mixed focus groups will be conducted to evaluate findings and foster consensus in the development of the care pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\u00a0Funding was awarded from April 2022 (NIHR202727). Both systematic review protocols were prospectively registered on PROSPERO in May 2022. Formal searches began thereafter. Approval by the University College London Research Ethics Committee (23563\/001) was received in December 2022. Data collection began in January 2023; data analysis will begin in May 2023 (completion expected by October 2023).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\u00a0This study will comprehensively encompass major interventions for management of pain in people with unresectable pancreatic cancer, and prevention and treatment of cachexia in people with pancreatic cancer. Key stakeholders will facilitate the development of an evidence-based care pathway, ensuring both acceptability and feasibility. The project ends in April 2024 and published results are expected within 12 months of completion. We aim to present the findings through patient group websites, conferences, and publications, irrespective of the findings, in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>International Registered Report Identifier (IRRID)<\/jats:title>\n                    <jats:p>DERR1-10.2196\/46335<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/46335","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T18:04:40Z","timestamp":1677434680000},"page":"e46335","source":"Crossref","is-referenced-by-count":3,"title":["Management of Pain and Cachexia in Pancreatic Cancer: Protocol for Two Systematic Reviews, Network Meta-Analysis, Surveys, and Focus Groups"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-5702","authenticated-orcid":false,"given":"Danielle Amanda","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-1315","authenticated-orcid":false,"given":"Eila","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6212-8948","authenticated-orcid":false,"given":"Christopher","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4840-9403","authenticated-orcid":false,"given":"Yarunnessa","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0231-1607","authenticated-orcid":false,"given":"Sarah","family":"Prideaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-6640","authenticated-orcid":false,"given":"Alwin","family":"Puthiyakunnel Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6798-5510","authenticated-orcid":false,"given":"Emilia","family":"Postaleniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7148-0003","authenticated-orcid":false,"given":"Jashan","family":"Selvakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8995-9776","authenticated-orcid":false,"given":"Mahta","family":"Haghighat Ghahfarokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-5907","authenticated-orcid":false,"given":"Brian","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0313-9134","authenticated-orcid":false,"given":"Kurinchi","family":"Gurusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"ref1","unstructured":"Cancer Today: estimated number of incident cases and deaths pancreas, both sexes, all agesInternational Agency for Research on Cancer (World Health Organization)20202023-03-09http:\/\/gco.iarc.fr\/today\/home"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24410"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx088"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.1000-9604.2015.02.05"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000791"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2017.05.011"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"ref8","unstructured":"Pancreatic cancer statisticsCancer Research UK20222023-03-09https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/pancreatic-cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4610-4"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89i9-S.7923"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/839503"},{"key":"ref12","unstructured":"Chemotherapy, radiotherapy and surgical tumour resections in England: treatment breakdown, 2013-2019Cancer Data (National Cancer Registration and Analysis Service)20222023-03-09https:\/\/www.cancerdata.nhs.uk\/treatments"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5561"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5553"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.5007"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1412"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.4948"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.9636"},{"key":"ref19","unstructured":"Symptoms of pancreatic cancerCancer Research UK20222023-03-09https:\/\/www.cancerresearchuk.org\/about-cancer\/pancreatic-cancer\/symptoms"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4488-z"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ans.13609"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2015.052"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007519.pub2"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v8.i8.599"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12083"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00967.x"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2005.03.012"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S167994"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9716"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016656"},{"key":"ref31","unstructured":"Palliative careWorld Health Organization20222023-03-09https:\/\/www.who.int\/health-topics\/palliative-care#:~:text=WHO%20has%20developed%20a%20three,patient%20is%20free%20of%20pain"},{"key":"ref32","unstructured":"Pancreatic cancer in adults: diagnosis and management. NICE guideline [NG85]National Institute for Health and Care Excellence20182023-03-09https:\/\/www.nice.org.uk\/guidance\/ng85"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061543"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12553"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00088"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.advms.2013.11.001"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare7030089"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i28.9361"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620938987"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12127"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i20.2430"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1159\/000098177"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2005.09.007"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000193"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30179-0"},{"key":"ref47","unstructured":"Pancreatic cancer (Germany) top 10James Lind Alliance Priority Setting Partnerships20202023-03-09https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/pancreatic-cancer-germany\/pancreatic-cancer-germany-top-10.htm"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002633"},{"key":"ref51","unstructured":"Good clinical practice network: glossaryInternational Council For Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use (ICH)20222023-03-09https:\/\/ichgcp.net\/1-glossary"},{"key":"ref52","unstructured":"World Health Organization International Clinical Trials Registry PlatformWorld Health Organization2023-03-21https:\/\/trialsearch.who.int\/"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"ref54","unstructured":"DiasSWeltonNJSuttonAJAdesAENICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trialsDecision Support Unit20162023-03-09https:\/\/www.sheffield.ac.uk\/find?query=TSD+2%3AA+general+linear+modelling+framework+for+pair-wise+and+network+ meta-analysis+of+randomised+controlled+trials&f.Tabs%7CAllDocumentsFill=All+results"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp014"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.57"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1037"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"ref59","unstructured":"DiasSWeltonNJSuttonAJCaldwellDMLuGAdesAENICE DSU technical support document 4: inconsistency in networks of evidence based on randomised controlled trialsDecision Support Unit20142023-03-09http\/\/\/C:\/Users\/A9075\/Downloads\/TSD4-Inconsistency.final_.15April2014.pdf"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.04.018"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.5.837"},{"key":"ref62","unstructured":"HigginsJPTThomasJChandlerJCumpstonMLiTPageMJWelchVACochrane Handbook for Systematic Reviews of Interventions (version 6.3)Cochrane20222023-03-09https:\/\/training.cochrane.org\/handbook"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6890"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6188"},{"key":"ref65","unstructured":"DiasSSuttonAJWeltonNJAdesAENICE DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment 2012Decision Support Unit20122023-03-09http\/\/\/C:\/Users\/A9075\/Downloads\/TSD3-Heterogeneity.final-report.08.05.12.pdf"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117"},{"key":"ref69","author":"Knowlton, LW","year":"2013","journal-title":"The Logic Model Guidebook: Better Strategies for Great Results. 2nd ed"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102563"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e46335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:52:46Z","timestamp":1782841966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e46335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":72,"URL":"https:\/\/doi.org\/10.2196\/46335","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.46335","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}